USMLE Renal: Nephritic Syndromes (PSGN, IgA, Goodpasture, ANCA Vasculitis)

What This Is and Why It Matters for USMLE

Nephritic syndromes, including PSGN, IgA nephropathy, Goodpasture syndrome, and ANCA-associated vasculitis, are high-yield topics for Step 1, Step 2 CK, and Step 3. These conditions are characterized by inflammation of the glomeruli and can lead to kidney failure if not treated promptly. They are frequently tested on the USMLE, particularly in the clinical vignette format, and require a strong understanding of pathophysiology, clinical presentation, and management.

High-Yield Facts (What You Must Memorize)

• Pathophysiology:
  • PSGN: immune complex deposition, complement activation
  • IgA nephropathy: IgA deposition, mesangial proliferation
  • Goodpasture syndrome: anti-GBM antibodies, linear IgG deposition
  • ANCA-associated vasculitis: ANCA antibodies, granulomatous inflammation
• Classic presentation and physical exam findings:
  • PSGN: hematuria, proteinuria, hypertension
  • IgA nephropathy: hematuria, proteinuria, often associated with upper respiratory tract infections
  • Goodpasture syndrome: hematuria, pulmonary hemorrhage, anti-GBM antibodies
  • ANCA-associated vasculitis: vasculitis, glomerulonephritis, often associated with systemic symptoms
• Diagnostic approach:
  • Labs: urine analysis, serum creatinine, complement levels
  • Imaging: renal ultrasound, biopsy
• First-line treatment and management:
  • PSGN: corticosteroids, immunosuppressive therapy
  • IgA nephropathy: corticosteroids, angiotensin-converting enzyme inhibitors
  • Goodpasture syndrome: corticosteroids, plasmapheresis
  • ANCA-associated vasculitis: corticosteroids, immunosuppressive therapy
• Red flags, complications, and follow-up:
  • PSGN: rapid progression to kidney failure, hypertension
  • IgA nephropathy: proteinuria, chronic kidney disease
  • Goodpasture syndrome: pulmonary hemorrhage, renal failure
  • ANCA-associated vasculitis: renal failure, pulmonary hemorrhage

Clinical Pearls & Buzzwords

• "Triple threat" in PSGN: hematuria, proteinuria, hypertension
• "IgA nephropathy" often associated with upper respiratory tract infections
• "Goodpasture syndrome" associated with anti-GBM antibodies
• "ANCA-associated vasculitis" often associated with systemic symptoms

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation (e.g., hematuria, proteinuria, hypertension)
2. Generate a differential (most likely and must-not-miss):
   • PSGN, IgA nephropathy, Goodpasture syndrome, ANCA-associated vasculitis
3. Order appropriate initial tests:
   • Urine analysis, serum creatinine, complement levels
   • Renal ultrasound, biopsy
4. Interpret results:
   • PSGN: immune complex deposition, complement activation
   • IgA nephropathy: IgA deposition, mesangial proliferation
   • Goodpasture syndrome: anti-GBM antibodies, linear IgG deposition
   • ANCA-associated vasculitis: ANCA antibodies, granulomatous inflammation
5. Initiate treatment and monitoring:
   • PSGN: corticosteroids, immunosuppressive therapy
   • IgA nephropathy: corticosteroids, angiotensin-converting enzyme inhibitors
   • Goodpasture syndrome: corticosteroids, plasmapheresis
   • ANCA-associated vasculitis: corticosteroids, immunosuppressive therapy

Common Mistakes & Exam Traps

• The mistake: Failing to consider Goodpasture syndrome in a patient with hematuria and pulmonary hemorrhage
• Why it happens: Misunderstanding of the classic presentation and failure to consider the "triple threat" in PSGN
• How to avoid it: Remember the classic presentation of Goodpasture syndrome and consider it in the differential diagnosis of hematuria and pulmonary hemorrhage

• Exam board insight: The examiners may penalize you for not considering Goodpasture syndrome in this scenario

• The mistake: Failing to order a renal biopsy in a patient with unexplained hematuria and proteinuria

• Why it happens: Rushing through the exam and failing to consider the importance of a renal biopsy in diagnosing IgA nephropathy
• How to avoid it: Take your time and consider the importance of a renal biopsy in diagnosing IgA nephropathy
• Exam board insight: The examiners may penalize you for not ordering a renal biopsy in this scenario

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology)
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with hematuria and proteinuria...")
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management

CCS (Step 3) Relevance (If Applicable)

• Initial orders:
  • Urine analysis, serum creatinine, complement levels
  • Renal ultrasound, biopsy
• Monitoring and follow-up:
  • Serial serum creatinine levels to monitor kidney function
  • Urine analysis to monitor for proteinuria and hematuria
• Common mistakes:
  • Failing to order a renal biopsy in a patient with unexplained hematuria and proteinuria
  • Failing to consider Goodpasture syndrome in a patient with hematuria and pulmonary hemorrhage

Practice Questions (3-5 single-best-answer)

Question 1: A 25-year-old patient presents with hematuria, proteinuria, and hypertension. Which of the following is the most likely diagnosis? A) PSGN B) IgA nephropathy C) Goodpasture syndrome D) ANCA-associated vasculitis

Answer: A) PSGN

Explanation: The patient's symptoms of hematuria, proteinuria, and hypertension are classic for PSGN.

Question 2: A 40-year-old patient presents with hematuria and pulmonary hemorrhage. Which of the following is the most likely diagnosis? A) PSGN B) IgA nephropathy C) Goodpasture syndrome D) ANCA-associated vasculitis

Answer: C) Goodpasture syndrome

Explanation: The patient's symptoms of hematuria and pulmonary hemorrhage are classic for Goodpasture syndrome.

Question 3: A 30-year-old patient presents with hematuria and proteinuria. Which of the following is the most likely diagnosis? A) PSGN B) IgA nephropathy C) Goodpasture syndrome D) ANCA-associated vasculitis

Answer: B) IgA nephropathy

Explanation: The patient's symptoms of hematuria and proteinuria are classic for IgA nephropathy.

Quick Reference Card (60-Second Summary)

• PSGN: hematuria, proteinuria, hypertension, corticosteroids, immunosuppressive therapy
• IgA nephropathy: hematuria, proteinuria, often associated with upper respiratory tract infections, corticosteroids, angiotensin-converting enzyme inhibitors
• Goodpasture syndrome: hematuria, pulmonary hemorrhage, anti-GBM antibodies, corticosteroids, plasmapheresis
• ANCA-associated vasculitis: vasculitis, glomerulonephritis, often associated with systemic symptoms, corticosteroids, immunosuppressive therapy

If You Get Stuck on Test Day

• How to eliminate obviously wrong answers:
  • Look for answers that are not supported by the patient's symptoms or lab results
  • Use the process of elimination to narrow down the options
• How to use the "next best step" hierarchy (least invasive, most specific):
  • Start with the least invasive tests (e.g., urine analysis, serum creatinine)
  • Gradually move to more specific tests (e.g., renal ultrasound, biopsy)
• For Step 3 CCS: what to order when unsure:
  • Basic labs (e.g., urine analysis, serum creatinine)
  • Vitals (e.g., blood pressure, pulse)
  • IV access (e.g., Foley catheter, IV fluids)

Related USMLE Topics

• Rapidly progressive glomerulonephritis connects to PSGN, Goodpasture syndrome, and ANCA-associated vasculitis
• Chronic kidney disease connects to IgA nephropathy, PSGN, and ANCA-associated vasculitis
• Hematuria connects to PSGN, IgA nephropathy, Goodpasture syndrome, and ANCA-associated vasculitis